Neuropsychopharmacology
- Social environment as a determinant of mismatch negativity in early psychosis11 months ago
- Prefrontal contribution to passive coping behaviour in chronic stress and treatment by fast-acting antidepressant12 months ago
- Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder12 months ago
- The generative AI blueprint: modeling brain and behavior in concert12 months ago
- Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain12 months ago
- Epigenetic regulation of brain development, plasticity, and response to early-life stress12 months ago
- Rewired realities: novel insights into the neurobiology of cannabis use disorder and psychosis12 months ago
Journal of Psychopharmacology
- Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes2 years ago
- Common protein networks for various drug regimens of major depression are associated with complement and immunity2 years ago
- Regular cannabis use modulates gamma activity in brain regions serving motor control2 years ago
- Psilocybin for clinical indications: A scoping review2 years ago
- Voluntary nicotine consumption and reward in a subset of diversity outbred founder strains2 years ago
- Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire2 years ago
- Adult rat ultrasonic vocalizations and reward: Effects of propranolol and repeated cocaine administration2 years ago
European Neuropsychopharmacology
- Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance2 years ago
- Addressing concerns of sample overlap in meta-analysis: A response to the letter by Ben Haouala and Amamou, 20242 years ago
- Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder2 years ago
- Points to consider when initiating clinical investigations in autistic paediatric populations–A White Paper2 years ago
- Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review2 years ago
- Methodological issues around the comorbidity of obsessive-compulsive disorder and bipolar disorder2 years ago
- Prader Willi syndrome, its psychiatric implications and their possible biological basis2 years ago